Usted buscó: aspergillus (Maltés - Inglés)

katalase miksub minn aspergillus niger,
catalase derived from aspergillus niger,

glucose oxydase miksub minn aspergillus niger,
glucose oxydase derived from aspergillus niger,

lipaż ta’ lipoproteina; proteiż alkalin aspergillus
lipoprotein lipase; aspergillus alkaline protease

xi iżolati reżistenti ġew identifikati minn aspergillus fumigatus avjarju.
some resistant isolates have been identified from avian aspergillus fumigatus.

din l-infezzjoni hija kkawżata minn moffa msejħa aspergillus.
this infection is caused by a mould called aspergillus.

6-phytase prodott minn aspergillus oryzae (dsm 17594)
6-phytase produced by aspergillus oryzae (dsm 17594)

voriconazole għandu attività fungiċida in vitro kontra l-aspergillus spp.
voriconazole has in vitro fungicidal activity against aspergillus spp.

aspergillus spp. 1 a. fumigatus a. flavus a. terreus a. niger
aspergillus spp.1 a. fumigatus a. flavus a. terreus a. niger

aspergillus fumigatus aspergillus flavus aspergillus niger aspergillus terreus aspergillus nidulans aspergillus versicolor
aspergillus fumigatus aspergillus flavus aspergillus niger aspergillus terreus aspergillus nidulans aspergillus versicolor

attwalment m’hemmx dejta suffiċjenti biex jiġu stabbiliti breakpoints kliniċi għal aspergillus spp.
there are currently insufficient data to set clinical breakpoints for aspergillus spp.

fil-preżent ma hemmx dejta biżżejjed sabiex jiġu stabbiliti breakpoints kliniċi għal aspergillus spp.
there are currently insufficient data to set clinical breakpoints for aspergillus spp.

informazzjoni limitata tissuġġerixxi li ħmejjer mhux candida u mofof mhux aspergillus inqas komuni mhumiex koperti minn caspofungin.
limited data suggest that less common non-candida yeasts and non-aspergillus moulds are not covered by caspofungin.

dawn huma l- pazjenti li huma l- aktar probabbli li jiżviluppaw infezzjoni tal- aspergillus.
these are the patients who are most likely to develop an aspergillus infection.

valuri ta’ limitu epidemjoloġiku (ecoff - epidemiological cut-off) għal aspergillus spp.
epidemiological cut-off (ecoff) values for aspergillus spp.

il- proporzjon kritiku għall- individwi b’ infezzjonijiet ta ’ aspergillus kienet ~200.
the critical ratio for subjects with aspergillus infections was ~200.

l-inċidenza tar-reżistenza għal caspofungin mid-diversi iżolati kliniċi ta’ aspergillus hija rari.
the incidence of resistance to caspofungin by various clinical isolates of aspergillus is rare.

bħalissa m‟hemmx biżżejjed dejta biex jiġu stabbiliti l-valuri kritiċi għal speċijiet oħrajn ta‟ aspergillus.
there are currently insufficient data to set clinical breakpoints for other aspergillus species.

l- inċidenza tar-reżistenza għal caspofungin mid-diversi iżolati kliniċi ta’ candida u aspergillus hija rari.
the incidence of resistance to caspofungin by various clinical isolates of candida and aspergillus is rare.

l - inċidenza tar- reżistenza għal caspofungin mid- diversi iżolati kliniċi ta ’ candida u aspergillus mhijiex magħrufa.
the incidence of resistance to caspofungin by various clinical isolates of candida and aspergillus is unknown.

l-iktar infezzjonijiet fungali invażivi li kienu rrappurtati b’mod komuni kienu jinkludu candida, pneumocystis, aspergillus, u histoplasma.
the most commonly reported invasive fungal infections included candida, pneumocystis, aspergillus, and histoplasma.